Asia-pacific Amniotic Membrane Market Forecast 2022-2030

Asia-pacific Amniotic Membrane Market Forecast 2022-2030

KEY FINDINGS

The Asia-Pacific amniotic membrane market is expected to record a CAGR of 7.69% during the forecast period, 2022-2030. The rising plastic surgeries and prevention surgeries of eyeglasses in South Korea, Japan, China, and India, offer growth opportunities.

MARKET INSIGHTS

Indonesia, South Korea, Thailand, Vietnam, Australia & New Zealand, China, Japan, India, and Rest of Asia-Pacific are assessed for the Asia-Pacific amniotic membrane market growth evaluation. In Japan, the key growth driver is the increasing number of plastic and cosmetic surgeries. These include pilling of skin, new skin-tone regeneration, skin glow treatment, and cosmetic eye surgery. Also, several hospital chains provide a wide range of treatments, surgery options, and transplants for patients. The other factor driving the use of AM in Japan is cornea disorders. Besides, many medical institutes like the University of Toyama, the Graduate School of Medicine and Pharmaceutical Sciences, and the Department of Regenerative Medicine are working in AM R&D.

In Indonesia, AM treatment is registered for cancer and ophthalmology. Also, prominent medicine and biologist experts are clinically engaged in placenta formation and grafts. In addition, a fresh amniotic membrane is increasingly preferred, given its vast availability and easy accessibility.

Further, in Australia, ophthalmologists and optometrists use AM grafts as a regenerative therapy for different ocular surface disease diagnoses under the special access TGA scheme. Additionally, processed AM AmnioTek allograft transplant for the ocular surface is available in Australia. Moreover, wound care treatment is very distinctive in New Zealand and Australia. As a result, the AM use is specific in both countries.

COMPETITIVE INSIGHTS

Some of the leading companies in the market are Smith & Nephew Plc, Celularity Inc, Organogenesis Inc, Skye Biologics Llc, etc.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Rising Incidents Of Burn Injuries And Traumatic Wounds
3.1.2. Increasing Research On Stem Cell Biology And Regenerative Medicine
3.1.3. Awareness Programs For Wound Care Treatment
3.2. Key Restraints
3.2.1. Limitations Associated With Use Of Amniotic Membrane
4. Key Analytics
4.1. Impact Of Covid-19 On Amniotic Membrane Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
5. Market By Product
5.1. Cryopreserved Amniotic Membrane
5.2. Lyophilization Amniotic Membrane
6. Market By Application
6.1. Surgical Wounds
6.2. Ophthalmology
6.3. Other Applications
7. Market By End-users
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Specialized Clinics
7.4. Research Centers & Laboratories
8. Geographical Analysis
8.1. Asia-pacific
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. China
8.1.5.2. Japan
8.1.5.3. India
8.1.5.4. South Korea
8.1.5.5. Indonesia
8.1.5.6. Thailand
8.1.5.7. Vietnam
8.1.5.8. Australia & New Zealand
8.1.5.9. Rest Of Asia-pacific
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.2. Company Profiles
9.2.1. Amino Technology Llc
9.2.2. Amino X Medical Inc
9.2.3. Bio-tissue Inc
9.2.4. Celularity Inc
9.2.5. Human Regenerative Technologies
9.2.6. Integra Lifesciences Corp
9.2.7. Katena Products Inc
9.2.8. Labtician Ophthalmics Inc
9.2.9. Mimedx
9.2.10. Organogenesis Inc
9.2.11. Skye Biologics Llc
9.2.12. Smith & Nephew Plc
9.2.13. Stryker Corporation
9.2.14. Surgenex Llc
9.2.15. Surgilogix Llc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings